| Style | Citing Format |
|---|---|
| MLA | Ehsani A, Soleimani N, Estehbani M M. "Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients." Iranian Journal of Medical Microbiology, vol. 19, no. 3, 2025, pp. 191-202. |
| APA | Ehsani A, Soleimani N, Estehbani M M (2025). Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients. Iranian Journal of Medical Microbiology, 19(3), 191-202. |
| Chicago | Ehsani A, Soleimani N, Estehbani M M. "Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients." Iranian Journal of Medical Microbiology 19, no. 3 (2025): 191-202. |
| Harvard | Ehsani A, Soleimani N, Estehbani M M (2025) 'Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients', Iranian Journal of Medical Microbiology, 19(3), pp. 191-202. |
| Vancouver | Ehsani A, Soleimani N, Estehbani M M. Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients. Iranian Journal of Medical Microbiology. 2025;19(3):191-202. |
| BibTex | @article{ author = {Ehsani A and Soleimani N and Estehbani M M}, title = {Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients}, journal = {Iranian Journal of Medical Microbiology}, volume = {19}, number = {3}, pages = {191-202}, year = {2025} } |
| RIS | TY - JOUR AU - Ehsani A AU - Soleimani N AU - Estehbani M M TI - Antibiotic Susceptibility, Biofilm Formation, and Phylogenetics of Pseudomonas Aeruginosa in Cystic Fibrosis Patients JO - Iranian Journal of Medical Microbiology VL - 19 IS - 3 SP - 191 EP - 202 PY - 2025 ER - |